Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients.

Baggio, G; Manzato, E; Gabelli, C; Fellin, R; Martini, S; Enzi, G B; Verlato, F; Baiocchi, M R; Sprecher, D L; Kashyap, M L

Baggio, G; Manzato, E; Gabelli, C; Fellin, R; Martini, S; Enzi, G B; Verlato, F; Baiocchi, M R; Sprecher, D L; Kashyap, M L.

J Clin Invest ; 77(2): 520-7, 1986 Feb.

Article in En | MEDLINE | ID: mdl-3944267

Subject(s)

Apolipoproteins C/deficiency; Lipase/blood; Lipoproteins/blood; Triglycerides/blood; Adult; Apolipoprotein C-II; Apolipoproteins C/genetics; Apolipoproteins C/therapeutic use; Chylomicrons/blood; Female; Genetic Variation; Humans; Lipoproteins, HDL/blood; Lipoproteins, LDL/blood; Lipoproteins, VLDL/blood; Male

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Apolipoproteins C / Triglycerides / Lipase / Lipoproteins Type of study: Prognostic_studies Limits: Adult / Female / Humans / Male Language: En Journal: J Clin Invest Year: 1986 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google